HULC and hepatocellular carcinoma: The overexpression of HULC in HCC cells increased the expression level of USP22, leading to a reduction in the ubiquitin-mediated degradation of COX-2 proteins, resulting in the upregulation of COX-2 expression and half-life prolongation.